NEW YORK (GenomeWeb News) — Researchers working with biomarkers may soon see a new set of guidelines that will cover how biomarkers should be used in clinical trials, the America Association for Cancer Research said last week.
 
The guidelines will be co-developed by the National Cancer Institute, the US Food and Drug Administration, the AACR, and a group of representatives from academia, industry, and patient advocates, as part of a group dubbed the Cancer Biomarker's Collaborative.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.